ESLAW

distress 8/10 · high distress / dilution risk

$0.06-17%today-55% from 52w high

estrellabio.comEmeryVille, CABiotechnology

Revenue

pre-revenue

Liquidity

$2M

Runway

0.2 yrs

Shares 1y

+16%

Price & events

-55.1% over 6M

CatalystRating changeDilutionFinancingdashed = today

-17.4%

-36.0%

-55.1%

—

-55.1%

All

Overview

Market Cap: $2.75M
Volume: 2.34K
52 Week Range: $0.06 – $0.14
Total Shares: 43.03M
Float Shares: 9.10M
RVOL: 1.54x
Beta: -0.09

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 43,034,228 · 2 offerings/1y · 1 PIPEs

2026-02-13424B3offering
2026-01-23EFFECTshelf_effective
2026-01-22S-1/Ashelf_registration
2026-01-16S-1/Ashelf_registration
2026-01-068-Kprivate_placement
2026-01-06424B5offering
2025-12-22S-1shelf_registration

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified